---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-124165"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T03:09:39.921337+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Orthofix enters $275M secured credit facility with Oxford Finance; repays Blue Torch loan

## Summary
- New credit agreement provides $160M term loan, $65M delayed draw, and up to $50M discretionary facility, maturing Nov 2029.
- Interest rate: greater of 8.75% or 5.75% plus 1-month SOFR; facility fee 1.5% of each funded tranche.
- Company terminated prior $275M credit agreement with Blue Torch Finance dated Nov 2023.
- Covenants require min $45M unrestricted cash at closing, $15M ongoing, and max 4.0x total debt-to-EBITDA leverage.
- Delayed draw Term B available from Jan 2025 to Jun 2026 subject to leverage compliance; Term C at Oxford's discretion.

## SEC filing metadata
- accession: 0000950170-24-124165
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017024124165/0000950170-24-124165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000095017024124165/ofix-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-124165
- JSON: https://secwatch.observer/filing/0000950170-24-124165.json
- Plain text: https://secwatch.observer/filing/0000950170-24-124165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.